‘Talking’ to vegetative state patients Boning up on joint replacement Cancer recovery prediction tool The ACE Study UHN receives $2.5 million to develop safer medical technologies Could natural sleep play a role in overcoming addiction? Antiplatelet agents battle to a standstill The glycoprotein IIb/IIIa inhibitor tirofiban (Aggrastat) is “non-inferior” to its more expensive counterpart abciximab (ReoPro) in ST-elevation MI patients undergoing percutaneous coronary intervention. New health research centre opens at York U Forceps OK after failed vacuum extraction Second-hand smoke bad for babies-to-be Study reinforces need for better public policy First Previous 832 833 834 835 836 Next Last
